About
Since 1978, Par Pharmaceutical has been at the forefront of developing, manufacturing, marketing and distributing safe, innovative and cost-effective pharmaceuticals that help improve patient quality of life. Every week in America, more than one million Par prescriptions are dispensed. In return for the trust that is placed in us, we are committed to providing products of uncompromising quality with the highest levels of service. In fulfilling this mission, we deliver value to our customers and the physicians and patients that rely on us. Today, the company’s sales place it among the top 5 largest generic pharmaceutical companies in the United States.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 23 investors are based in Malvern, Pennsylvania, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Malvern, US
Contact Information
Find more investors like Par
Search Investors